Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
R01 DK099465
NIDDK NIH HHS - United States
PubMed
31348885
DOI
10.1016/j.cell.2019.07.002
PII: S0092-8674(19)30741-X
Knihovny.cz E-resources
- Keywords
- COP vesicles, ER stress, Golgi apparatus, cargo receptor, endoplasmic reticulum, epithelial cells, kidney, organoids, secretory pathway, unfolded protein response,
- MeSH
- Benzamides chemistry metabolism pharmacology MeSH
- Epithelial Cells cytology metabolism MeSH
- Heptanes pharmacology therapeutic use MeSH
- Imidazoline Receptors antagonists & inhibitors genetics metabolism MeSH
- Induced Pluripotent Stem Cells cytology metabolism MeSH
- Kidney cytology metabolism pathology MeSH
- Humans MeSH
- Lysosomes drug effects metabolism MeSH
- RNA, Small Interfering metabolism MeSH
- Mucin-1 chemistry genetics metabolism MeSH
- Bridged Bicyclo Compounds pharmacology therapeutic use MeSH
- Mice, Transgenic MeSH
- Mice MeSH
- Kidney Diseases metabolism pathology MeSH
- Frameshift Mutation MeSH
- RNA Interference MeSH
- Unfolded Protein Response drug effects MeSH
- Activating Transcription Factor 6 metabolism MeSH
- Vesicular Transport Proteins chemistry metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- ATF6 protein, human MeSH Browser
- Benzamides MeSH
- BRD4780 MeSH Browser
- Heptanes MeSH
- Imidazoline Receptors MeSH
- RNA, Small Interfering MeSH
- Mucin-1 MeSH
- Bridged Bicyclo Compounds MeSH
- NISCH protein, human MeSH Browser
- TMED9 protein, human MeSH Browser
- Activating Transcription Factor 6 MeSH
- Vesicular Transport Proteins MeSH
Intracellular accumulation of misfolded proteins causes toxic proteinopathies, diseases without targeted therapies. Mucin 1 kidney disease (MKD) results from a frameshift mutation in the MUC1 gene (MUC1-fs). Here, we show that MKD is a toxic proteinopathy. Intracellular MUC1-fs accumulation activated the ATF6 unfolded protein response (UPR) branch. We identified BRD4780, a small molecule that clears MUC1-fs from patient cells, from kidneys of knockin mice and from patient kidney organoids. MUC1-fs is trapped in TMED9 cargo receptor-containing vesicles of the early secretory pathway. BRD4780 binds TMED9, releases MUC1-fs, and re-routes it for lysosomal degradation, an effect phenocopied by TMED9 deletion. Our findings reveal BRD4780 as a promising lead for the treatment of MKD and other toxic proteinopathies. Generally, we elucidate a novel mechanism for the entrapment of misfolded proteins by cargo receptors and a strategy for their release and anterograde trafficking to the lysosome.
Broad Institute of MIT and Harvard Cambridge MA USA
Department of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School Boston MA USA
References provided by Crossref.org
Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors
A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis
Autosomal dominant tubulointerstitial kidney disease: A review
An intermediate-effect size variant in UMOD confers risk for chronic kidney disease
Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β